Effects of agar (kanten) diet on obese patients with impaired glucose tolerance and type 2 diabetes

Diabetes, Obesity and Metabolism

Volumn 7, Issue 1, 2005, Pages 40-46

  Maeda, Hajime ^a,b   Yamamoto, R ^a   Hirao, K ^a   Tochikubo, O ^b  

^a HEC Science Clinic   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Agar; Diabetes; Diet; IGT; Obesity

Indexed keywords

AGAR; GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY FAT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DIETARY FIBER; DISEASE ASSOCIATION; EATING HABIT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

EID: 12744274871     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2004.00370.x     Document Type: Article

References (38)

1. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dierz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523-1529.
2. Sono H, Ito H, Ohashi Y, Akanuma Y, Yamada N. Japan Diabetes Complication Study Group, obesity and type 2 diabetes in Japanese patients. Lancet 2003; 361: 85.
3. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1996; 19: 287-291.
4. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with life style intervention or metformin. N Engl J Med 2002; 346: 393-404.
5. Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D. Long-term effects of modest weight loss in type 2 diabetic patients. Arch Intern Med 1987; 147: 1749-1753,.
6. Redmon JB, Raatz SK, Reck KP et al. One-year outcome of a combination weight loss therapies for subjects with type 2 diabetes: a randomized trial. Diabetes Care 2003; 9: 2505-2511.
7. Anderson JW, Brinkman-Kaplan V, Hamilton CC, Logan JE, Collins RW, Gustafson NJ. Food-containing hypocaloric diets are as effective as liquid-supplement diets for obese individuals with NIDDM. Diabetes Care 1994; 17: 602-604.
8. Amatruda JM, Richeson JF, Well SL, Brodows RG, Lockwood DH. The safety and efficacy of a controlled low-energy diet in the treatment of non insulin dependent diabetes and obesity. Arch Intern Med 1988; 148: 873-877.
9. Tong PC, Lee ZS, Sea MM et al. The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with and without type 2 diabetes. Arch Intern Med 2002; 162: 2428-2435.
10. Okauchi N, Mizuno A, Yoshimoto S, Zhu M, Sano T, Shima T. Is caloric restriction effective in preventing diabetes mellitus in the Othuka Long Evans Tokusima fatty rat a model of spontaneous non-insulin dependent diabetes mellitus. Diabetes Res Clin Pract 1995; 27: 97-106.
11. Salmeron J, Ascherio D, Jenkins DJ, Stampfer MJ, Wing AL, Willett WC. Dietary fiber, Glycemic load, and risk of NIDDM in men. Diabetes Care 1997; 20: 545-550.
12. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, Glycemic load, and risk of NIDDM in women. JAMA 1997; 277: 472-477.
13. Landin K, Holm G, Tengborn L, Smith U. Guar gum improves insulin sensitivity,blood lipids, blood pressure, and fibrinolysis in healthy men. Am J Clin Nutr 1992; 56: 1061-1065.
14. Chandelia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley LJ. Beneficial effect of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 2000; 342: 1392-1398.
15. The Examination Committee of Criteria for 'Obesity Disease' in Japan. Japan Society for Study of Obesity. New criteria for 'obesity disease' in Japan. Jpn Circ J 2002; 66: 987-992.
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
17. Matthews DR, Hoster JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β -cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419.
18. Cleland SJ, Petrie JR, Morris AD, Ueda S, Dorrian CA, Connell JM. FIRI: a fair insulin resistance index. Lancet 1996; 347: 770.
19. Duncan MH, Singh BM, Wise PH, Carter G, Alaghband-Zadeh J. A simple measure of insulin resistance. Lancet 1995; 346: 120-121.
20. Levine R, Haft D. Carbohydrate homeostasis. N Engl J Med 1970; 283: 237-246.
21. Myllynen P, Koivisto V, Nikkila E. Glucose intolerance and insulin resistance accompany immobilization. Acta Med Scand 1987; 222: 75-81.
22. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987; 36: 54-59.
23. Reaven JM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1606.
24. Abate N, Garg A, Peshock RM, Stray-Gunderson J, Adams-Huet B, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 1996; 45: 1684-1693.
25. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997; 46: 1579-1585.
26. Mourier A, Gautier JF, A et al. Mobilization of visceral adipose tissue related to the improvement of insulin sensitivity in response to physical training in NIDDM: effects of branched-chain amino acid supplements. Diabetes Care 1997; 20: 385-391,.
27. Després J-P, Pouliot MC, Bouchard C et al. Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Physiol 1991; 261: E159-E167.
28. Fujioka S, Matsuzawa Y, Tarui S et al. Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. Int J Obes 1991; 15: 853-859.
29. Rice B, Janssen I, Hudson R, Rose R. Effect of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese man. Diabetes Care 1999; 22: 684-691.
30. Defronzo RA, Tobin JD, Andres R. The Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 16: E214-E223.
31. Jenkins DJA, Goff DV, Hockaday TDR et al. Unabsorbable carbohydrates and diabetes: decreased postprandial hyperglycemia. Lancet 1976; 2: 172-174.
32. Holt S, Heading RC, Carter DC, Prescott LF, Tothill P. Effect of gel fibre on gastric emptying and absorption of glucose and paracetamol. Lancet 1979; 24: 636-639.
33. Calle-Pascual AL, Marenco G, Asis MJ, Marañes JP, Charro AL. Effects of different proportions of carbohydrates, polysaccarides/monosaccharides, and different fibers on the metabolic control in diabetic rats. Metabolism 1986; 35: 919-923.
34. Gardner DF, Schwartz L, Krista M, Merimee TJ. Dietary pectin and glycemic control in diabetes. Diabetes Care 1984; 7: 143-146.
35. Vuksan V, Sievenpiper JL, Stavro MP et al. Konjac-mannan and American ginseng: emerging alternative therapies for type 2 diabetes mellitus. J Am Coll Nutr 2001; 20: 370S-380S.
36. Vuksan V, Sievenpiper JL, Novokmet R et al. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care 2000; 23: 9-14.
37. Venter CS, Kruger HS, Vorster HH et al. The effect of dietary component konjacglucomannan on serum cholesterol levels of hypercholesterolemic subjects. Hum Nutr Food Sci Nutr 1987; 41: 55-61.
38. Beattie VA, Edwards CA, Hosker JP et al. Does adding fibre to a low energy, high carbohydrate, low fat diet confer any benefit to the management of newly diagnosed overweight type 2 diabetics? BMJ 1988; 296: 1147-1149.